Literature DB >> 23203680

Neuroendocrine carcinoma of the urinary bladder: a retrospective study of CT findings.

Andrew C Boyer1, S Zafar Jafri, S Mohammad A Jafri, Mitual B Amin.   

Abstract

PURPOSE: The purpose of this study was to evaluate the radiographic features of neuroendocrine carcinoma of the urinary bladder (NECB) on CT and to review the literature regarding carcinogenesis, treatment, and prognosis.
METHODS: The presenting CT of patients with pathology-proven NECB were retrospectively reviewed for features including size and appearance of the bladder mass, the presence of hydronephrosis, bladder wall thickening, invasion of perivesical fat, lymph nodes, and distant metastasis. Follow-up imaging and the medical record were reviewed to determine patient treatment and overall survival.
RESULTS: Sixteen patients (13 males, 3 females) were diagnosed with NECB with a mean age of 75.5 years (range 48-90). The characteristic CT appearance was a large polypoid bladder mass (average size 4.9 cm). Extension into the perivesical fat, adjacent organ involvement, and distant metastases were common.
CONCLUSION: NECB is an aggressive primary neoplasm of the bladder that presents on CT as a large bladder mass with local extension into the perivesical fat, involvement of adjacent organs, and metastasis.

Entities:  

Mesh:

Year:  2013        PMID: 23203680     DOI: 10.1007/s00261-012-9971-6

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  2 in total

Review 1.  Imaging of neuroendocrine neoplasms of the male GU tract.

Authors:  Kedar G Sharbidre; Ajaykumar C Morani; Mohd Zahid; Priya Bhosale; Chandana Lall; Isaac R Francis; Sadhna Verma
Journal:  Abdom Radiol (NY)       Date:  2022-04-12

2.  Application of contrast-enhanced ultrasonography for large cell neuroendocrine carcinoma in the urinary bladder: a case report.

Authors:  Wei Li; Ze-Zhen Su; Ji-Hui Kang; Xiao-Yan Xie; Xiao-Hua Xie; Bo-Wen Zhuang
Journal:  BMC Med Imaging       Date:  2020-05-03       Impact factor: 1.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.